Publisher's Note. Urology's big start to 2025.
| Publicado en: | Urology Times Vol. 53; no. 5; p. 8 |
|---|---|
| Autor principal: | |
| Formato: | brief item Journal Article |
| Publicado: |
MJH Life Sciences
May2025
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186232303&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 186232303 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00939722 URO jtl: Urology Times issn: 00939722 maglogo: N pubinfo: dt: May2025 vid: 53 iid: 5 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 186232303 186232303 186232303 186232303 ppf: 8 ppct: 0 formats: fmt: @attributes: type: P tig: atl: Publisher's Note. Urology's big start to 2025. aug: au: HENNESSY JR, MIKE sug: subj: Urology American Society of Clinical Oncology Congresses and Conferences United States United States United States Food and Drug Administration Drug Approval Antibodies, Monoclonal Therapeutic Use Bladder Neoplasms Drug Therapy pubtype: Academic Journal doctype: brief item Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|